GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Pretax Margin %

Piramal Pharma (NSE:PPLPHARMA) Pretax Margin % : 8.91% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Piramal Pharma's Pre-Tax Income for the three months ended in Mar. 2024 was ₹2,275 Mil. Piramal Pharma's Revenue for the three months ended in Mar. 2024 was ₹25,524 Mil. Therefore, Piramal Pharma's pretax margin for the quarter that ended in Mar. 2024 was 8.91%.

The historical rank and industry rank for Piramal Pharma's Pretax Margin % or its related term are showing as below:

NSE:PPLPHARMA' s Pretax Margin % Range Over the Past 10 Years
Min: -1.7   Med: 4.83   Max: 23.37
Current: 2.19


NSE:PPLPHARMA's Pretax Margin % is ranked worse than
55.53% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 4.15 vs NSE:PPLPHARMA: 2.19

Piramal Pharma Pretax Margin % Historical Data

The historical data trend for Piramal Pharma's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Pretax Margin % Chart

Piramal Pharma Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Pretax Margin %
23.37 7.46 -1.70 2.19

Piramal Pharma Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.39 -6.12 2.07 0.99 8.91

Competitive Comparison of Piramal Pharma's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Piramal Pharma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Piramal Pharma's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Piramal Pharma's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Piramal Pharma's Pretax Margin % falls into.



Piramal Pharma Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Piramal Pharma's Pretax Margin for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=1792.9/81711.6
=2.19 %

Piramal Pharma's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=2274.8/25523.6
=8.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Piramal Pharma  (NSE:PPLPHARMA) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Piramal Pharma Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Piramal Pharma (NSE:PPLPHARMA) Business Description

Traded in Other Exchanges
Address
Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070
Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines